DEUTZ Aktiengesellschaft (ETR:DEZ) reported a strong start to fiscal 2026, with management pointing to accelerating momentum in orders, improved profitability, and continued progress on the company’s transformation into five business units. On the company’s first-quarter earnings call, CEO Sebastian Schulte said DEUTZ “started really, really positively” in what he described as an “exciting but also […]

LeMaitre Vascular (NASDAQ:LMAT) reported first-quarter 2026 results highlighted by double-digit revenue growth, expanding profitability, and continued momentum in its Artegraft franchise, which management said is now the company’s largest product. Quarter performance driven by grafts, international growth, and pricing CEO George LeMaitre said the quarter “featured 11% sales growth, a 72.7% gross margin, and 42% […]

S4 Capital (LON:SFOR) reported first-quarter 2026 results shaped by “volatile global macroeconomic conditions and ongoing client caution,” according to CFO Radhika Ghai, while management reiterated full-year guidance and pointed to improved leverage and liquidity following cost actions and debt repurchases. Q1 results show revenue declines, EBITDA in line with expectations Ghai said first-quarter revenue totaled […]

GRAIL (NASDAQ:GRAL) reported first-quarter fiscal 2026 results highlighting higher test volumes and screening revenue growth, alongside updates on its FDA premarket approval (PMA) review and upcoming clinical data presentations. Executives also discussed commercial partnerships, electronic health record integrations, and how recent NHS-Galleri trial headlines have shaped stakeholder questions ahead of additional data disclosures at ASCO […]

Cumberland Pharmaceuticals (NASDAQ:CPIX) executives highlighted a planned strategic transaction with Apotex, updates across several marketed brands, and progress in the company’s late-stage pipeline during the company’s first-quarter 2026 earnings call. Apotex deal to acquire marketed products for $100 million Chief Executive Officer A.J. Kazimi said Cumberland has entered into an agreement with Apotex, which he […]

Qualys (NASDAQ:QLYS) reported first-quarter 2026 results that management said reflected continued revenue growth and profitability, while emphasizing a product strategy centered on “pre-breach” risk management, exploit validation, and autonomous remediation. The company also raised its full-year revenue and earnings outlook modestly, citing a solid start to the year but maintaining a generally cautious view on […]

Remitly Global (NASDAQ:RELY) reported what executives repeatedly described as a record-setting first quarter of 2026, with revenue and profitability exceeding management’s guidance as the company benefited from strong customer acquisition, rising activity from higher-value segments, and continued cost discipline. On the earnings call, CEO Sebastian Gunningham—now roughly 90 days into the role—outlined operating priorities and […]

PureCycle Technologies (NASDAQ:PCT) reported what management called its “strongest” business momentum to date entering 2026, pointing to production gains at its Ironton, Ohio facility, sequential revenue growth, and increased branded customer conversions during its first quarter 2026 corporate update call. Operational progress at Ironton and turnaround execution CEO Dustin Olson said Ironton produced 8.4 million […]

Noodles & Company (NASDAQ:NDLS) reported first-quarter 2026 results that management said showed “consistent and sustainable favorable results” across sales and profitability, supported by improved restaurant execution, more disciplined marketing, and ongoing menu initiatives. Sales momentum extends into April Chief Executive Officer Joe Christina said the company delivered system-wide comparable sales growth of more than 9% […]

Hudson Technologies (NASDAQ:HDSN) reported first-quarter 2026 revenue growth and outlined a series of operational and leadership changes that management said are intended to support longer-term, more diversified growth, even as profitability declined year over year due to product mix and higher expenses tied in part to an enterprise resource planning (ERP) rollout. First-quarter results show […]

Chime Financial (NASDAQ:CHYM) reported a “strong start” to fiscal 2026 in its first-quarter earnings call, highlighting record active member totals, accelerating product launches, expanding profitability, and an increased outlook for the full year. Co-founder and CEO Chris Britt said the company delivered “strong active member growth,” “continued taking share from the largest banks,” and achieved […]

Barrett Business Services (NASDAQ:BBSI) reported first-quarter 2026 results that management said were “in line with our expectations,” citing continued client growth initiatives and progress in its benefits and technology offerings despite ongoing macro-related client workforce reductions. First-quarter results and worksite employee trends President and CEO Gary Kramer said the company had a “solid start to […]

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported first-quarter 2026 total revenue of $268 million, and executives said the company is maintaining its full-year outlook as it advances a pipeline led by remlifanserin in Alzheimer’s disease psychosis and trofinetide in Japan. Chief Executive Officer Catherine Owen Adams said the quarter represented “a solid start to the year,” with total […]

Amplitude (NASDAQ:AMPL) executives highlighted first-quarter fiscal 2026 results, accelerating AI-focused product development, and a newly announced strategic partnership involving Statsig during the company’s earnings call. First-quarter results show ARR growth and improving expansion CEO Spenser Skates said Amplitude delivered $94 million in Q1 revenue, up 17% year-over-year, and exited the quarter with $374 million in […]

Navitas Semiconductor (NASDAQ:NVTS) reported first-quarter 2026 results that management said marked “another quarter of solid progress” in its ongoing shift toward higher-power markets, with revenue returning to sequential growth and high-power applications making up a larger share of the business. President and CEO Chris Allexandre said the company has “meaningfully accelerated” its pivot away from […]

Lineage (NASDAQ:LINE) reported first-quarter 2026 results that came in ahead of management’s expectations, as the cold storage operator pointed to early signs of stabilization amid elevated industry supply and trade-related pressure. President and CEO Greg Lehmkuhl said the quarter “reinforces our view that the business is stabilizing as we manage through the industry headwinds we’ve […]

Super Micro Computer (NASDAQ:SMCI) reported fiscal third-quarter 2026 results marked by sharp year-over-year growth, a sequential revenue decline tied to customer site readiness delays, and a notable rebound in gross margin. The company also addressed a recent U.S. Department of Justice indictment involving former associated individuals, emphasizing that Super Micro is not a defendant or […]

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported first-quarter 2026 net sales of $311.3 million as executives said demand for its MASH therapy Rezdiffra continued to build in a market they described as still early in development. On the company’s earnings call, management highlighted patient growth, expanding diagnosis and specialist engagement, and progress toward a broader MASH pipeline that […]

Huron Consulting Group (NASDAQ:HURN) opened 2026 with revenue growth across all three operating segments and continued margin expansion, prompting management to affirm its full-year guidance. Executives emphasized sustained demand in healthcare and commercial advisory work, improving conditions in the education buying environment, and continued investment in artificial intelligence capabilities as a long-term growth driver. First-quarter […]

Interparfums (NASDAQ:IPAR) reported first-quarter 2026 results that management said were broadly in line with expectations, with reported net sales rising 2% to $345 million as growth in the Americas and favorable foreign exchange offset softness in several international regions impacted by macro conditions and conflict. Sales trends: strength in the Americas, pressure in parts of […]

American Coastal Insurance (NASDAQ:ACIC) executives said the company delivered another profitable quarter while navigating what management described as a rapidly softening commercial property insurance market, highlighting stable underwriting margins, a completed June 1 catastrophe reinsurance renewal, and early progress in its excess and surplus (E&S) initiative. Management cites disciplined underwriting amid softening market President and […]

Freshworks (NASDAQ:FRSH) reported first-quarter 2026 results that management said exceeded expectations on revenue, profitability, and free cash flow, driven by continued momentum in its employee experience (EX) business and ongoing operational efficiency efforts. First-quarter results and key metrics Chief Executive Officer and President Dennis Woodside said Freshworks “delivered a strong start to 2026,” with revenue […]

Ferroglobe (NASDAQ:GSM) reported higher shipment volumes in its fiscal first quarter of 2026 as trade actions and safeguards supported demand for its alloy products, even as pricing and cost pressures weighed on profitability. Management also discussed efforts to broaden the company’s addressable market through additional “critical materials” opportunities and an expanded relationship with battery company […]

Integra LifeSciences (NASDAQ:IART) reported first-quarter 2026 results that exceeded the high end of management’s guidance ranges, while also outlining leadership changes and reiterating its full-year revenue outlook. Leadership transition and commercial emphasis Chairman Stuart Essig said he has “stepped back into the role as President and CEO” and will retain his role as Chairman. Essig […]

Bioventus (NASDAQ:BVS) reported first-quarter 2026 results that management said put the company “off to a strong start” as it increased investment in several growth drivers while still expanding profitability and cash generation. On the call, the company also raised guidance for adjusted earnings per share and cash from operations, while reaffirming its full-year revenue outlook. […]

Angi (NASDAQ:ANGI) executives used the company’s first-quarter 2026 earnings call to outline what CEO Jeff Kip described as a strategic pivot toward an “AI native” technology platform and a suite of AI agents intended to improve outcomes for homeowners and service professionals. The company also discussed first-quarter results, the decision to stop providing guidance, early […]

EVgo (NASDAQ:EVGO) reported first-quarter 2026 results management said were in line with expectations, highlighted by record quarterly revenue and continued network expansion. Chief Executive Officer Badar Khan said the company is investing in growth while advancing a next-generation charging architecture it expects to begin rolling out by the end of the year. Q1 revenue rises […]

Atkore (NYSE:ATKR) reported sequential improvement in its fiscal 2026 second quarter results, supported by higher volumes, modest price increases, and ongoing productivity initiatives, while also absorbing a major litigation-related charge tied to the PVC pipe antitrust matter. Quarterly results show sequential gains President and CEO Bill Waltz said the company was “pleased with our second […]

Kraft Heinz (NASDAQ:KHC) reported first-quarter 2026 results that management said came in ahead of internal expectations, citing a smaller-than-anticipated decline in organic net sales and early signs of market share improvement tied to increased investments. Chief Executive Officer Steve Cahillane cautioned, however, that consumer sentiment remains low amid macroeconomic and geopolitical uncertainty, and that the […]

DHI Group (NYSE:DHX) reported first-quarter 2026 results that reflected continued growth at ClearanceJobs and improved profitability, even as total company revenue and bookings declined year-over-year due to ongoing weakness at Dice. Management pointed to signs of stabilization in the tech hiring market, strong free cash flow generation, and momentum tied to increased defense spending as […]

Upstart (NASDAQ:UPST) reported strong first-quarter 2026 growth while reiterating full-year guidance, as newly appointed CEO Paul Gu and newly hired CFO Andrea Blankmeyer emphasized a strategy centered on capital-efficient expansion, improving AI-driven underwriting, and scaling newer lending products without materially changing the company’s reliance on third-party funding. Management frames strategy around growth and capital efficiency […]

Archer Daniels Midland (NYSE:ADM) reported first-quarter 2026 adjusted earnings per share of $0.71 and total segment operating profit of $764 million, as management pointed to a more constructive margin environment in crushing and ethanol and raised its full-year outlook. Chair and CEO Juan Luciano said soybean crush and ethanol margins “strengthened meaningfully” as the market […]

SURO Capital (NASDAQ:SSSS) reported a sharp increase in net asset value during its first-quarter 2026 earnings call, driven primarily by unrealized appreciation across its venture-backed portfolio. Management also outlined a board-approved proposal to transition from an internally managed business development company (BDC) to an externally managed structure through a new advisor jointly owned by members […]

Talen Energy (NASDAQ:TLN) reported first-quarter 2026 results that management said reflected strong operational performance through winter weather events, continued tightening in PJM power markets, and the early benefits of recent acquisitions. The company also reaffirmed its 2026 guidance, outlined a preliminary outlook for 2027 and 2028 that includes its pending Cornerstone acquisition, and provided an […]

QuidelOrtho (NASDAQ:QDEL) said its first-quarter 2026 results were pressured by a meaningfully weaker respiratory season, distributor caution in China ahead of expected national IVD pricing guidelines, and some order delays tied to Middle East disruptions, while management reiterated expectations for improved profitability and cash generation later in the year. Management cites softer respiratory season and […]

Socket Mobile (NASDAQ:SCKT) reported first-quarter 2026 revenue of $3.7 million, with management citing continued customer caution and delayed spending that carried over from 2025. On the company’s earnings call, Chief Executive Officer Kevin Mills said the operating environment “remains difficult” and acknowledged revenue “fell short of expectations.” Despite the lower volume, Mills pointed to improved […]

Myriad Genetics (NASDAQ:MYGN) reported first-quarter fiscal 2026 revenue of $200.4 million, reflecting 2% year-over-year growth and landing within the company’s prior guidance range. Management highlighted continued momentum in hereditary cancer testing and GeneSight, partially offset by a year-over-year decline in prenatal testing volumes. The company reaffirmed its full-year 2026 guidance while emphasizing stepped-up commercial and […]

InnovAge (NASDAQ:INNV) reported fiscal third-quarter 2026 results that management said reflected “stronger operating execution” and the benefits of investments made to strengthen its platform. The company, which operates Programs of All-Inclusive Care for the Elderly (PACE) centers, posted approximately $252 million in total revenue, a center-level contribution margin of $61 million, and adjusted EBITDA of […]

Cytokinetics (NASDAQ:CYTK) highlighted the first full quarter as a commercial-stage company during its first-quarter 2026 earnings call, pointing to early U.S. demand for its newly launched hypertrophic cardiomyopathy (HCM) drug MYQORZO, a recent European approval, and positive top-line results from the Phase 3 ACACIA-HCM trial of aficamten in non-obstructive HCM (nHCM). MYQORZO U.S. launch delivers […]

Atomera (NASDAQ:ATOM) executives said the company made progress across several customer engagements during its first-quarter 2026 earnings call, highlighting momentum in advanced logic, memory, RF, power devices, and gallium nitride (GaN) applications for its Mears Silicon Technology (MST). Gate-All-Around focus and customer evaluations President and CEO Scott Bibaud said Atomera is prioritizing Gate-All-Around (GAA) transistors […]

UFP Technologies (NASDAQ:UFPT) reported first-quarter 2026 results that management said reflected a solid start to the year, led by continued growth in its medical business and progress on strategic capacity and program expansion initiatives. Quarterly performance driven by medical growth Chief Executive Officer and Chairman R. Jeffrey Bailly said revenue increased 4.1% year over year, […]

Pinterest (NYSE:PINS) reported stronger-than-expected first-quarter 2026 results and emphasized ongoing efforts to translate growing engagement into more consistent monetization, driven by AI-powered product improvements, measurement upgrades, and changes to its go-to-market organization. Q1 results top guidance as revenue exceeds $1 billion again CEO Bill Ready said Pinterest entered 2026 focused on “delivering the next phase […]

Surgery Partners (NASDAQ:SGRY) executives said first-quarter results were broadly in line with internal expectations, as the outpatient surgery operator saw improving stability across its portfolio and early signs of recovery in areas that were pressured late in 2025. On the company’s first quarter 2026 earnings call, Chief Executive Officer Eric Evans said Surgery Partners entered […]

uniQure (NASDAQ:QURE) executives outlined progress and upcoming regulatory milestones for lead Huntington’s disease gene therapy candidate AMT-130 during the company’s first-quarter 2026 earnings call, while also providing updates across its epilepsy and Fabry programs and reviewing quarterly financial results. AMT-130 regulatory strategy centers on FDA engagement and a planned U.K. filing Chief Executive Officer Matt […]

Orthofix Medical (NASDAQ:OFIX) reported first-quarter 2026 results that management said reflect steadier execution, improving stability, and the early benefits of actions taken to reset its Spine commercial channel. Total global net sales for the quarter ended March 31, 2026 were $196.4 million, up 3% year-over-year on a pro forma constant currency basis, excluding discontinued M6 […]

IDEXX Laboratories (NASDAQ:IDXX) reported first-quarter 2026 results that management described as an “exceptional start” to the year, driven by continued execution in its companion animal business and contributions from recent innovations. First-quarter results driven by companion animal diagnostics Chief Financial Officer Andrew Emerson said IDEXX’s first-quarter revenue increased 14% as reported and 11% organically. He […]

Fortrea (NASDAQ:FTRE) reported first-quarter 2026 results that management said reflect improving commercial traction, operational execution, and ongoing cost discipline, while the contract research organization reiterated its full-year guidance. Management cites stabilizing demand and sustained booking momentum Chief Executive Officer Anshul Thakral said the market backdrop is “gradually becoming more favorable,” pointing to more constructive dialogue […]

Horizon Quantum Computing Pte. (NASDAQ:HQ) outlined hiring-driven spending increases, an expanded hardware partnership roster, and progress on its software stack during its first-quarter fiscal 2026 earnings call, while emphasizing that it is prioritizing technical execution over near-term revenue generation. Management highlights software roadmap and “tight integration” with hardware Founder and CEO Dr. Joe Fitzsimons opened […]

Travere Therapeutics (NASDAQ:TVTX) executives highlighted a first-quarter marked by an FDA approval, record demand for FILSPARI in IgA nephropathy, and renewed progress in the company’s late-stage pipeline, according to remarks on the company’s first quarter 2026 financial results call. FDA approval expands FILSPARI into FSGS President and CEO Eric Dube said April 13 “marked a […]

Evolus (NASDAQ:EOLS) reported first-quarter results that management said reflected a stronger operating model following cost structure changes implemented last year, while reiterating its full-year 2026 outlook for double-digit revenue growth and adjusted EBITDA profitability. First-quarter results and profitability progress President and CEO David Moatazedi said Evolus began 2026 with “strong momentum” and delivered its “second […]